Bioceres Crop Solutions Corp. BIOX
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -32.24% | -32.41% | -13.98% | -10.30% | 7.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -32.24% | -32.41% | -13.98% | -10.30% | 7.95% |
| Cost of Revenue | -30.40% | -30.12% | -14.16% | -10.72% | 11.59% |
| Gross Profit | -35.03% | -35.98% | -13.69% | -9.70% | 2.89% |
| SG&A Expenses | -1.47% | -1.31% | -2.80% | -2.46% | -4.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -92.61% | -78.26% | -54.47% | 32.44% | 131.15% |
| Total Operating Expenses | -25.24% | -24.73% | -11.85% | -6.55% | 9.01% |
| Operating Income | -102.64% | -112.29% | -38.14% | -38.55% | -1.68% |
| Income Before Tax | -1,098.81% | -647.14% | -250.55% | -113.12% | -26.21% |
| Income Tax Expenses | 110.15% | -72.78% | -252.48% | -423.08% | 136.86% |
| Earnings from Continuing Operations | -1,767.00% | -944.90% | -248.39% | -86.51% | -72.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 402.48% | 217.95% | 108.23% | 53.39% | -1,301.70% |
| Net Income | -2,353.42% | -1,394.08% | -361.81% | -88.46% | -81.75% |
| EBIT | -102.64% | -112.29% | -38.14% | -38.55% | -1.68% |
| EBITDA | -79.61% | -86.88% | -21.08% | -25.55% | 3.87% |
| EPS Basic | -2,336.93% | -1,388.38% | -363.84% | -88.62% | -82.00% |
| Normalized Basic EPS | -480.51% | -353.18% | -336.95% | -122.63% | -66.22% |
| EPS Diluted | -2,953.53% | -1,574.92% | -420.85% | -90.84% | -85.37% |
| Normalized Diluted EPS | -566.37% | -380.77% | -355.38% | -124.86% | -71.03% |
| Average Basic Shares Outstanding | 0.36% | 0.13% | 0.23% | 0.59% | 1.08% |
| Average Diluted Shares Outstanding | -1.83% | -2.05% | -1.18% | 1.84% | 3.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |